Thread
:
OBI Pharma transfers exclusive rights to develop, commercialize Dificid (fidaxomicin)
View Single Post
10-04-2015, 11:00 PM
#
1
News
Senior Member
Join Date: Oct 2007
Posts: 18,955
OBI Pharma transfers exclusive rights to develop, commercialize Dificid (fidaxomicin)
OBI Pharma, Inc. today announced an agreement with MSD, known as Merck in the United States and Canada, through a subsidiary transferring exclusive rights to develop and commercialize Dificid (fidaxomicin) in Taiwan to MSD.
More...
News
View Public Profile
Send a private message to News
Find More Posts by News